Site Search

Share

X

Search Results

Rhode Island Senate Votes to Remove Barriers to Biomarker Testing

... right patient, at the right time,’ precision medicine has played a critical role in improving cancer outcomes – biomarker testing being one of the ways we can achieve these outcomes by allowing doctors to understand and target unique markers in a patient’s cancer cells. Despite its benefits, access to biomarker testing has not kept pace with the rate of innovation due in part to lack of coverage by private health insurance and Medicaid for needed testing. Senate Bill 2201 aims to enable more ...

PA House Insurance Committee Votes to Remove Barriers to Biomarker Testing

Today, the House Insurance Committee voted to improve Pennsylvanians’ access to biomarker testing, advancing House Bill 1754 out of committee unanimously. Championed by Representatives Kyle Mullins and Minority Leader Bryan Cutler, the proposal would ensure biomarker testing ... Senate. The following is a statement from Donna Greco, Government Relations Director for the American Cancer Society Cancer Action Network (ACS CAN) in Pennsylvania: "Biomarker testing and precision medicine are helping extend and improve lives by tailoring care and treatment to a person’s individual condition. Over the past few months, we have heard countless stories of the difficulties and inconsistencies patients face in attempting to access this important testing. It’s time for that to change. "This ...

Three-time Cancer Survivor Urges Lawmakers to Expand Access to Biomarker Testing

Link to video and interview SANTA FE – February 8, 2023 - The American Cancer Society Cancer Action Network (ACS CAN) hosted a ‘Cancer Action Day’ at the state capitol in conjunction with the New Mexico Allied Council on Tobacco (NMACT), today. Joyce ... is failing to keep pace with innovations and advancements in biomarker testing and treatment. This leaves some patients with the decision of paying for these tests out-of-pocket or going without this information. As a result, not all communities are benefitting from the latest advancements in biomarker testing and ...

Legislation Aimed at Improving Health Outcomes for New Yorkers Heads to Governor Hochul’s Desk

... / Assembly Bill 1673a to the Governor’s desk, giving her 10 days to take action on the legislation. Their proposal aims to ensure millions of New Yorkers can access precision care by requiring all state-regulated health plans to cover comprehensive biomarker testing. Biomarker testing opens the door to treatments that can lead to fewer side effects, improved survival, better quality of life and potentially lower costs for patients.  Advocates are hopeful that Governor Hochul will sign the legislation without any amendments to ...

Advocates Call on Washington Lawmakers to Prioritize Expanding Access to Biomarker Testing

... biomarker testing. Biomarker testing is about identifying the most effective treatment for patients with cancer and other serious illnesses. It can open the door to precision treatments that can improve outcomes and quality of life for patients with many diseases and conditions. Similar legislation has passed in 20 states including California, Texas, Georgia and New ... costs and avoiding potentially life-altering side effects.  It’s notable that biomarker testing is increasingly important to the treatment of conditions outside of the cancer space, like arthritis and other autoimmune conditions, organ and tissue transplant, and rare diseases. Research ...

New York State Senate Votes to Remove Barriers to Biomarker Testing

... Medicaid, when patients need it. This legislative victory came several hours after the American Cancer Society Cancer Action Network (ACS CAN) hosted cancer patients and survivors at the Capitol to honor National Cancer Survivors Day.   Biomarker testing has revolutionized cancer treatment over the last few decades and is increasingly important in the treatment of other conditions, providing access to targeted treatment and tailoring care to a person’s individual disease. Targeted therapies often result in improved quality of life and survivorship. For example, patients with certain lung cancer types who received biomarker testing and then a targeted therapy saw a 31% ...

NJ Assembly Financial Institutions & Insurance Committee Votes to Improve Access to Biomarker Testing

... Financial Institutions & Insurance Committee voted to improve New Jerseyans’ access to biomarker testing, advancing Assembly Bill 4163 out of committee. Championed by Assemblymembers Shavonda Sumter, Gary Schaer and Shama Haider, the proposal would ensure biomarker testing is covered ... Senate. The following is a statement from Quinton Law, Government Relations Director for the American Cancer Society Cancer Action Network (ACS CAN) in New Jersey: "Biomarker testing and precision medicine are helping extend and improve lives by tailoring care and treatment to a person’s individual condition. Over the past few months, we have heard countless stories of the challenges patients face in attempting to access this important testing. It’s time for that to change.” "This legislation addresses a ...

Proposal Aimed at Improving Health Outcomes for Mainers Secures Overwhelming Support from Voters

... Committee on Health Coverage, Insurance and Financial Services will consider LD 1577. The American Cancer Society Cancer Action Network (ACS CAN) urges Committee members to support the bill, which aims to expand coverage for biomarker testing—when medically appropriate—to Mainers insured through state-regulated health plans, including Medicaid.   Biomarker testing is a tool utilized by physicians across a variety of specialties to connect patients to the right treatment at the right time. It has become a game-changing part of cancer care by opening the door to targeted treatments that can lead to improved survivorship and quality of life. Despite the proven benefits ...

Cancer Survivors Thank New Mexico State Lawmakers for Passing Biomarker Testing Bill

SANTE FE – MARCH 20, 2023 – The American Cancer Society Cancer Action Network (ACS CAN) applauds members of the New Mexico State Legislature for passing House Bill 73 as the 2023 legislative session ended. With the signature of Governor Michelle Lujan Grisham, the bill will expand access to biomarker testing statewide, helping to revolutionize cancer care in New ...

Expand Access to Biomarker Testing in Delaware

Biomarker testing helps connect patients with the right treatment at the right time.  ACS CAN and partners are working together to make sure more Delaware residents can benefit from this important testing!  Video of maggies_biomarker_story   What is Biomarker Testing? In cancer care, biomarkers are often used to help determine the best treatment for a patient . A “ biomarker ” is a sign of a normal biological process, disease or abnormal function that can be measured in blood, tissue or bodily fluid.  Biomarker testing  is the ...

Type

Priority Issue

State

Policy Issue

Judicial Advocacy